Treatment of high risk AML and MDS with Ara-C-Containing standard chemotherapy followed by reduced-intensity conditioning allogeneic stem cell transplantation (RIC-SCT) during Aplasia: a survey of the German Cooperative Transplant Study Group (GCTSG)

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Jolanta B. Dengler, Matthias Stelljes, Cathrin Theuser, Ute Hegenbart, Christoph SchmidORCiDGND, Joachim Kienast, Anthony D. Ho, Gerhard Ehninger, Peter Dreger, Martin Bornhaeuser
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/100012
URL:https://ashpublications.org/blood/article/108/11/5376/130986/Treatment-of-High-Risk-AML-and-MDS-with
ISSN:0006-4971OPAC
ISSN:1528-0020OPAC
Parent Title (English):Blood
Publisher:American Society of Hematology
Place of publication:Washington, DC
Type:Article
Language:English
Year of first Publication:2006
Release Date:2022/12/07
Tag:Cell Biology; Hematology; Immunology; Biochemistry
Volume:108
Issue:11
First Page:5376
DOI:https://doi.org/10.1182/blood.v108.11.5376.5376
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie
Medizinische Fakultät / Professur für Transplantation und Zelltherapieforschung

OPUS4 Logo